Partners

Alamar Biosciences

Lead Partner

AlamarDropLogo_4c - - 13th Alzheimer's & Parkinsons Drug Development Summit

Alamar Biosciences is powering precision proteomics with automated, high-throughput solutions for ultra-high sensitivity protein analysis across a range of multiplex levels in liquid biopsy samples. Our proprietary NULISA™ Chemistry utilizes a novel sequential capture-and-release method, reducing background signal and increasing sensitivity and dynamic range compared with standard approaches. The NULISA Platform allows for a fully automated workflow with the ARGO™ System, enabling less than 30 minutes hands-on time from sample to data.

www.alamarbio.com

Lumanity

Hosting Partner

Lumanity applies incisive thinking and decisive action to cut through complex situations and deliver transformative outcomes to accelerate and optimize access to medical advances. With deep experience in medical, commercial, and regulatory affairs, Lumanity transforms data and information into real world insights and evidence that powers successful commercialization and empowers patients, providers, payers, and regulators to take timely and decisive action. Contact us to learn more about how Lumanity can support your unique challenge.

www.lumanity.com

Atuka

Expertise Partner

Atuka provides contract research and consultancy services for the biopharmaceutical industry with world-leading expertise in Parkinson’s disease and related neurological conditions. We provide cutting-edge, rodent and non-human primate models (toxin and molecular pathology-driven) to evaluate efficacy and target engagement over a comprehensive range of symptomatic, motor (e.g. parkinsonism and dyskinesia), non-motor (e.g. cognition and impulse control) and disease-modification assays. Atuka also offers biodistribution (e.g. AAVs, ASOs) and non-GLP safety assessments in non-human primates, DMPK and in-vivo imaging services to aid development of novel therapeutics.

www.atuka.com

Transpharmation

Program Partner

Transpharmation is an accredited preclinical contract research organization specializing in translational pharmacology across various therapeutic areas. We offer neuroscience expertise, utilizing behavioral and molecular assays to help clients benchmark compounds. With extensive experience in antibiotic treatments and diet manipulations, we study their effects on the microbiome. Committed to on-time data delivery and providing flexible, customized solutions, we support clients in optimizing preclinical assets for the development of life-changing medicines.

www.transpharmation.com

Elixirgen Scientific

Program Partner

CND Life Sciences

Program Partner

CND Life Sciences is a medical technology company offering cutaneous testing and biomarker services for neurodegenerative disorders. The Syn-One Test® detects, visualizes, and quantifies misfolded alpha-synuclein in cutaneous nerves with greater than 95% sensitivity and specificity to aid in the diagnosis of Parkinson’s disease and related disorders. The test utilizes a simple in-office skin biopsy procedure to provide clinicians and patients with unique pathological insights as early in the disease process as possible. CND collaborates with biopharmaceutical companies to help optimize clinical trials for investigational drugs by quantifying alpha-synuclein in cutaneous nerves and measuring its volume over time with assistance from the company’s NerValence AI-based system.

www.cndlifesciences.com

Catalent Pharma Solutions

Event Partner

With more than 35 products launched in over 60 countries, the Zydis® ODT (orally disintegrating tablet) fast-dissolve technology continues to be the world’s best-in-class ODT technology. The Zydis fast-dissolve platform consists of three technologies: Zydis ODT, Zydis Ultra, and Zydis Bio. Zydis ODT is a unique freeze-dried dosage form that disperses within three seconds without the need for water. Zydis Ultra technology offers enhanced taste-masking capabilities, increased drug loading, and the potential for functional coating. Zydis Bio technology offers a formulation strategy for oral delivery of peptides, allergens, and viral vaccines.

www.catalent.com

Quanterix

Exhibition Partner

From discovery to diagnostics, Quanterix’s ultrasensitive biomarker detection is fueling breakthroughs only made possible through the Company’s unparalleled sensitivity and flexibility. Its industry-leading Simoa® precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding, management and patient care in neurology, oncology, immunology, cardiology and infectious disease for nearly two decades.

www.quanterix.com

BrainXell

Exhibition Partner

BrainXell provides high-purity, iPSC-derived human neurons and glia for research and development with a focus on drug discovery. Utilizing proprietary technology, we generate high purity, subtype-specific neurons that mature rapidly and are quickly andeasily ready for a variety of assays. Multiple neuron subtypes relevant to a range of disorders are available. Additionally, each neuron subtype can be made in custom batches from 50 million to 10 billion neurons from unique iPSC lines. We are dedicated to delivering the highest quality products for off-the-shelf neurons and custom service projects.

www.brainxell.com

BioIVT

Exhibition Partner

BioIVT's Center for NeuroExcellence is the largest private global source of longitudinally collected human cerebrospinal fluid (CSF) from control as well as diseased populations. Samples are available immediately and are collected under US IRB-approved protocols. Our biorepository consists of CSF, CSF cell pellet collections, as well as additional banked biomaterial matched to CSF including PAXGene RNA, serum, plasma, blood cell pellet, and urine. All are prospectively consented and include detailed longitudinal clinical data.

https://bioivt.com

Ariadne. Ai

Innovation Partner

ariadne.ai ag is your partner for biomedical image analysis. Our cloud-based, worry-free SPATIAL platform enables the analysis of multiplexed spatial proteomics, transcriptomics and multi-omics data, including precise stitching, registration, segmentation and statistical analyses of cellular neighborhoods. SPATIAL works with any data type, whether you have fluorescence or histopathological staining, 2d or 3d data, or complex cell types such as neurons. Our experienced team of annotators and software engineers will design and implement custom solutions to any image analysis challenge, no matter the tissue, device or assay.

www.ariadne.ai.com

Unlearn. AI

Innovation Partner

At Unlearn, we believe that AI will not just revolutionize medicine—it will redefine it, transforming the lives of millions. Our mission is clear: to advance AI to eliminate trial and error in medicine.
Today, we’re pioneering digital twins of patients that solve key pain points across clinical development, delivered through the Unlearn Platform. And this is just the beginning. In the future, our technology will transform medicine into a computational science. As we continuously improve our AI, we aim to shape a future where precision medicine becomes the norm, setting a new standard of care that enables better health outcomes for all.

www.unlearn.ai.com

FUJIFILM

Event Partner

FUJIFILM Cellular Dynamics, Inc. (FCDI) is a leading developer and supplier of human induced pluripotent stem cells (iPSCs) utilized in drug discovery and cell therapies. The company uses its expertise in iPSC technologies to develop a robust pipeline of life science research tools, including iCell® products. These cells are highly pure, highly reproducible, and available in industrial quantities in many cell types and sourced from multiple cell lines which can be applied for drug discovery, target identification and toxicity testing.

Please visit: www.fujifilmcdi.com